Dr Nathalie MAUBON

Dr Nathalie MAUBON
Dr Nathalie MAUBON
CEO/CSO
HCS Pharma
Poster Presenter

LinkedIn
Poster Presentation Poster 109
Development of neuroprotection model for Parkinson disease using High Content Screening
Poster Presentation Poster 110
Hepatotoxicity assays by High Content Analysis

Profile of Dr Nathalie MAUBON

With 15 years of experience in the pharmaceutical research (public research, pharmaceutical industry in Fournier, Solvay and Abbott labs and biotechnology company), Nathalie MAUBON is a specialist in the development and automation of robust models for high-throughput screening (HCS , HTS , ADMET). She moved several positions managing projects to general direction, via managing teams and services.
Today she has decided to combine the expertise of researchers from the public on the mechanism of a disease, with the researchers from industry in automation and high throughput screening, by creating HCS Pharma, a biotechnology company specialised in development of phenotypic screening using High Content Screening technology (http://www.hcs-pharma.com).
Email
Please login to send a Private Message

Hosted By
ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
www.myeventflo.com/1791
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018